Newsfeeds - Spark Newswire

2 minute read

Celsion, Hainan Poly Pharm Sign Agreement To Manufacture Celsion’s DNA-Based Vaccine; Terms Not Disclosed

Today, 7:57 PM

Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, and Hainan Poly Pharm Co. Ltd. (Shenzhen Stock Exchange 300630.SZ), a generics

CLSN

1 minute read

Celsion’s Vaccine Platform Shows Potential Against COVID-19 In Preclinical Studies

By Vandana Singh

Today, 7:57 PM

Celsion Corporation (NASDAQ:CLSN) has announced results from preclinical in vivo studies of its next-generation PLACCINE DNA vaccine platform. Data showed that…

CLSN

3 minute read

Celsion Reports T-cell, B-cell Response From In Vivo Studios With Its PLACCINE DNA Vaccine Platform

By Benzinga Newsdesk

Today, 7:57 PM

Results Indicate Induction of Adaptive Immune Response Against SARS-CoV-2 Company Plans Additional Development Work to Further Optimize its Vaccine Platform Through Vector Compositions, Delivery Route, Dosing and Dosing

CLSN

5 minute read

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma

By Shanthi Rexaline

Today, 7:57 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11)

ABCL

1 minute read

Celsion Q2 EPS $(0.06) Up From $(0.18) YoY, Sales $125.00K, Same YoY

By Benzinga Newsdesk

Today, 7:57 PM

Celsion (NASDAQ:CLSN) reported quarterly losses of $(0.06) per share. This is a 66.67 percent increase over losses of $(0.18) per share from the same period last year. The company reported $125.00 thousand in sales this

CLSN

15 minute read

Earnings Scheduled For August 12, 2021

By Benzinga Insights

Today, 7:57 PM

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.

AACG

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 7:57 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

4 minute read

31 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 7:57 PM

Gainers

ATHE

3 minute read

FDA
News

Celsion Reports Commencement Of Enrollment In Oxford University’s Phase 1 Study With Its ThermoDox, Focused Ultrasound In Pancreatic Cancer

By Benzinga Newsdesk

Today, 7:57 PM

Celsion Corporation (NASDAQ:CLSN), Celsion GmbH, a wholly owned subsidiary of Celsion Corporation, a clinical-stage biotechnology company, announces commencement of enrollment in Oxford University’s Phase I PanDox

CLSN

3 minute read

News

Celsion Says Establishes Wholly Owned Subsidiary To Manage Investigator-Sponsored Development Of ThermoDox

By Benzinga Newsdesk

Today, 7:57 PM

Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, announces that its new wholly owned subsidiary, Celsion GmbH, will manage all current and

CLSN